Cargando…

ROR1 is a pseudokinase that is crucial for MET-driven tumorigenesis

Detalles Bibliográficos
Autores principales:	Lazzari, Luca, Gentile, Alessandra, Benvenuti, Silvia, Trusolino, Livio, Comoglio, Paolo M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624144/ http://dx.doi.org/10.1186/1753-6561-7-S2-P43

Ejemplares similares

The Met oncogene and basal-like breast cancer: another culprit to watch out for?
por: Gastaldi, Stefania, et al.
Publicado: (2010)

Reviving oncogenic addiction to MET bypassed by BRAF (G469A) mutation
por: Virzì, Anna Rita, et al.
Publicado: (2018)

MET Activation and Physical Dynamics of the Metastatic Process: The Paradigm of Cancers of Unknown Primary Origin
por: Stella, Giulia M., et al.
Publicado: (2017)

Activation of HER family members in gastric carcinoma cells mediates resistance to MET inhibition
por: Corso, Simona, et al.
Publicado: (2010)

β4 integrin activates a Shp2–Src signaling pathway that sustains HGF-induced anchorage-independent growth
por: Bertotti, Andrea, et al.
Publicado: (2006)

Ockham’s razor for the MET-driven invasive growth linking idiopathic pulmonary fibrosis and cancer
por: Stella, Giulia M., et al.
Publicado: (2016)

Discovery of molecular determinants of response to targeted therapies in colorectal cancer using patient-derived xenografts (‘xenopatients’)
por: Sassi, Francesco, et al.
Publicado: (2013)

Erratum to: Ockham’s razor for the MET-driven invasive growth linking idiopathic pulmonary fibrosis and cancer
por: Stella, Giulia M., et al.
Publicado: (2017)

C-met inhibition blocks bone metastasis development induced by renal cancer stem cells
por: D'Amico, Lucia, et al.
Publicado: (2016)

A receptor-antibody hybrid hampering MET-driven metastatic spread
por: Modica, Chiara, et al.
Publicado: (2021)

Novel synthetic RORγ agonist compounds as a potential anti-tumor therapeutic approach
por: Hu, Xiao, et al.
Publicado: (2014)

An mTOR feedback loop mediates the ‘flare’ (‘rebound’) response to MET tyrosine kinase inhibition
por: Altintas, D. M., et al.
Publicado: (2023)

What is the point of pseudokinases?
por: Raju, Saravanan, et al.
Publicado: (2015)

Safety of targeting ROR1 for cancer immunotherapy with chimeric antigen receptor-modified T cells in a primate model
por: Berger, S Carolina, et al.
Publicado: (2014)

Unsupervised learning is crucial to learning the names of objects
por: Lillicrap, Timothy P, et al.
Publicado: (2007)

Identifying features of the lentiviral genome crucial for the establishment of latency
por: Ziglio, Serena, et al.
Publicado: (2013)

The crucial role of osteocyte-derived RANKL in bone homeostasis
por: Nakashima, Tomoki, et al.
Publicado: (2012)

Are energy and protein targets being met in the ICU?
por: Booth, R, et al.
Publicado: (2015)

Pseudokinase is active after all
por: LeBrasseur, Nicole
Publicado: (2008)

Nucleotide-binding mechanisms in pseudokinases
por: Hammarén, Henrik M., et al.
Publicado: (2016)

Tribbles Pseudokinases in Colorectal Cancer
por: Ferreira, Bibiana I., et al.
Publicado: (2021)

Pseudokinases, Tribbles Proteins and Cancer
por: Velasco, Guillermo, et al.
Publicado: (2023)

MET∆14 promotes a ligand-dependent, AKT-driven invasive growth
por: Cerqua, Marina, et al.
Publicado: (2022)

Neurophysiological pitfalls in TTR-FAP Val30Met
por: Conceição, Isabel, et al.
Publicado: (2015)

Expression of c-met gene in invasive ductal carcinomas
por: Park, CH, et al.
Publicado: (2005)

MetAMOS: a metagenomic assembly and analysis pipeline for AMOS
por: Treangen, Todd J, et al.
Publicado: (2011)

An Observatory for the MET Oncogene: A Guide for Targeted Therapies
por: Altintas, Dogus M., et al.
Publicado: (2023)

SCYL pseudokinases in neuronal function and survival
por: Pelletier, Stephane
Publicado: (2016)

Pharmacological Targeting of the Pseudokinase Her3
por: Xie, Ting, et al.
Publicado: (2014)

The Meckel-Gruber Syndrome protein TMEM67 (meckelin) regulates basal body planar polarization and non-canonical Wnt signalling via Wnt5a and ROR2
por: Abdelhamed, Z, et al.
Publicado: (2015)

The role of Met, Src and Stat3 in basal-like breast cancer invasion
por: Carefoot, E, et al.
Publicado: (2013)

Specific ocular changes in TTR Met30-FAP after liver transplantation
por: Ferreira, Natalia, et al.
Publicado: (2015)

Immune studies in a mouse model of MET and CAT induced liver tumors
por: Eggert, Tobias, et al.
Publicado: (2014)

Bacterial load plays a crucial role for survival in experimental peritonitis and modulates immunoparalysis of monocytes
por: Atmatzidis, S, et al.
Publicado: (2010)

A270 THE PREBIOTIC, INULIN, IMPACTS TUMORIGENESIS PROMOTION BY COLIBACTIN-PRODUCING
por: Oliero, M, et al.
Publicado: (2023)

MET Oncogene Controls Invasive Growth by Coupling with NMDA Receptor
por: Gallo, Simona, et al.
Publicado: (2022)

Pseudokinases-remnants of evolution or key allosteric regulators?
por: Zeqiraj, Elton, et al.
Publicado: (2010)

The real role of pseudokinase: linking diabetes to cancers
por: Li, Ke, et al.
Publicado: (2016)

Tribbles Pseudokinase 3 Regulation and Contribution to Cancer
por: Stefanovska, Bojana, et al.
Publicado: (2021)

P138 Nocturnal oxygen desaturation and MET call criteria during in-laboratory sleep studies
por: Stonehouse, J, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2q7jor8ui5t30ej1tb6l3196jv